What They Build
Molbio develops molecular diagnostic platforms and assays, including portable PCR-based systems for infectious disease testing in decentralized settings.
Why They Matter
Diagnostics matter when they leave central labs and change care in smaller clinics, districts, and public-health settings. Molbio matters because its platform addresses portability and speed in a country where access is a technical and logistical problem. The challenge is sustaining assay breadth, quality, and distribution.
Founders
Sriram Natarajan
Recent Milestones
- Truenat platform deployed
- Tuberculosis and infectious disease assays commercialized
- Large growth funding disclosed